HOME >> MEDICINE >> NEWS
Progress toward an antitumor vaccine

carbon atoms coupled together through a sulfur atom). To this end, the carrier protein is first equipped with a spacer, which has an allyl group (two carbon atoms attached by a double bond) at its end. The glycopeptide is coupled to a building block that causes thiols (sulfurhydrogen groups) to protrude from the molecule. In the next, light-initiated (photochemical) reaction, only the desired thioether bonds are formedno side reactions occur at other locations in the peptide chain.

Synthetic glycopeptide antigens containing structural elements typical of tumors in the sugar as well as the protein segment, explains Kunz, can thus be attached to the carrier protein in a controlled fashion. The largely nonimmunogenic thioether bridges could clear the way for the development of vaccines for immunization against tumor cells.


'"/>

Contact: Horst Kunz
hokunz@mail.uni-mainz.de
49-613-139-22334
John Wiley & Sons, Inc.
13-Jun-2007


Page: 1 2

Related medicine news :

1. Malaria 2007 -- Progressing research, persisting challenges
2. March 30 public briefing on PEPFARs Progress
3. Progression of diabetic retinopathy among African-Americans with diabetes
4. Progress slow in improving hospitals patient safety systems
5. Progress conference on child survival as called for in 2003 Lancet series to take place next week
6. Albert Szent-Gyrgyi Prize for Progress in Cancer Research to Harvards Harold F. Dvorak, M.D.
7. Free public talk on epilepsy research and progress towards better treatment
8. New study in Sleep finds a high level of negativity towards judicial sleepiness
9. Kenya moves toward national food and nutrition policy
10. A sweet step toward new cancer therapies
11. Comprehensive reforms to move toward patient-centered care released by ACP

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progress toward antitumor vaccine

(Date:3/31/2015)... March 31, 2015 The New ... Care Administrators (ACHCA) elected two administrators from Windsor ... long-term care in New Jersey, to two key ... new officers. Robert Reyes, administrator for Abingdon Care ... president, and Yael Herman, administrator of Canterbury Care ...
(Date:3/31/2015)... March 31, 2015 Williams Comfort ... repair visit when their home comfort is at ... make the visit fit into the customer’s schedule, ... fast, quality repair at requested times. , ... commercial customers in the Indianapolis area can visit ...
(Date:3/31/2015)... 31, 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... developed new-onset Type 2 diabetes due to the use ... the federal multidistrict litigation now underway in U.S. District ... issued on March 26th, jury selection for the proceeding’s ... (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502) , ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... Practice Edition 2, bringing the industry’s most advanced ... the healthcare community. Physicians can now experience the ... a trusted source, offering value-added support services that ... (EHR) systems. , “QMedET is proud to provide ...
(Date:3/31/2015)... CirugiaPlastica-Mexico.net , an exclusive plastic ... company, announced today an expansion of providers in ... most experienced and committed plastic surgeons in Mexico, ... elegant, life-altering cosmetic enhancements. Overall, a larger number ... in Mexico due to the improved technology, greater ...
Breaking Medicine News(10 mins):Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 3Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4
(Date:3/31/2015)... PARIS , March 31, 2015 ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced ... CHU de Grenoble (university hospital center). The CHU de ... France to propose to its gastroenterology, interventional ... research and a higher standard of care thanks to ...
(Date:3/31/2015)... Mar. 30, 2015 Research and Markets ... of the "Eurpoean Automatic External Defibrillators (AED) ... Public Access Market, Hospitals, Alternate Care Market, Home) ... offering. The European automated external defibrillator ... CAGR of 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... Mich. , March 31, 2015  The efficacy ... was highlighted in a recently published study 1 ... infection prevention research team, including Curtis Donskey , ... was run for the same length of time from ... xenon (PU-UV) unit.  The results showed surprisingly low pathogen ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4
Cached News: